My site

SAN FRANCISCO-Friday 31 July 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- Andersen Global announces its entrance into Cotonou, Benin with the addition of collaborating firm Fiduciaire Conseil and Assistance (FCA), a full-service tax and legal firm founded 20 years ago.

The firm, led by Managing Partner Sybel Akuesson, combines a strong, balanced tax and legal practice whose staff of 17 professionals provides assistance in labor law and corporate law as well as offers full tax capabilities to businesses involved in a variety of industries.

“In an increasingly complex world, the African market has begun demanding a new pace and scale of doing business, especially when it comes to the demand of legal services,” Sybel said. “In the spirit of stewardship, we are always looking for ways to grow and improve as a firm, and our collaboration with Andersen Global ensures we can meet all of our clients’ tax and legal needs globally in a seamless manner ... Read more »

Emesent’s AL2 for Hovermap Leverages Velodyne Lidar to Access the Inaccessible

 – Designation Based on Phase 2 Data and Reinforces Significant Treatment Need for HR-MDS –

– Pevonedistat Could be First Novel Treatment Option for HR-MDS in More Than a Decade –

CAMBRIDGE, Mass. & OSAKA, Japan-Thursday 30 July 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for its investigational drug pevonedistat for the treatment of patients with higher-risk myelodysplastic syndromes (HR-MDS). Pevonedistat, a first in class NEDD8-activating enzyme (NAE) inhibitor, could be the first novel treatment for HR-MDS patients in more than a decade, expanding treatment options that have so far been limited to hypomethylating agent (HMA) monotherapy alone. Even with current treatment options, outcomes for people living with HR-MDS remain poor.

The Breakthrough Therapy Des ... Read more »

- Empagliflozin significantly reduced the risk of cardiovascular death or hospitalization for heart failure versus placebo in the EMPEROR-Reduced heart failure trial. The study evaluated adults with heart failure with reduced ejection fraction

- Treatment of heart failure is an important unmet need with over half of those diagnosed dying within five years1

INGELHEIM, Germany & INDIANAPOLIS, US-Thursday 30 July 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Positive top-line results from the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with and without diabetes, were announced today by Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY). EMPEROR-Reduced met its primary endpoint, demonstrating superiority with empagliflozin (10 mg) compared to placebo in reducing the risk for the composite of cardiovascular death or hospitalization due to heart failure, when added to standard of care. Overall, the ... Read more »

GENEVA-Friday 31 July 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- International organizations released Ten Digital Economy Guidelines in alignment with the G20 Leaders’ policy directives that aim at securing sustainable economic growth. The Guidelines were adopted by the Union of Arab Banks (UAB), Union of Arab Chambers (UAC), International Network for SMEs (INSME), and the Global Coalition for Efficient Logistics (GCEL) to set the foundation for successfully implementing the Digital Economy.

The Digital Economy has been a key G20 policy directive since 2015. However, until today, no one has defined the Digital Economy, nor how it can be deployed to rebalance and grow the high, mid and low-income economies.

Following 15 years of R&D on digitizing the global economy, an international Coalition is leading a global economic development program that digitally “Jump Starts” national economies and their trade partners through a Digital Econo ... Read more »